Skip to main content

Day: August 23, 2023

Quorum Announces Q2 2023 Results

Revenue at $10.0M, Adjusted Cash Income1 increases by 46% over prior year CALGARY, Alberta, Aug. 23, 2023 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX-V: QIS) (OTC Pink: QIFTF) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment Manufacturers (“OEMs”) rely on for their operations, released its results today for the second quarter of 2023, ended June 30, 2023. Financial references are expressed in Canadian dollars unless otherwise indicated. Please refer to the MD&A and Financial Statements posted onto SEDAR related to non-IFRS measures and risk factors. “We are happy to report record total revenue of $10.0 million, a first for Quorum, and improved profitability for the second quarter of 2023. Throughout Q2...

Continue reading

Perseus Mining Updates Mineral Resources and Ore Reserves

Perth, Aug. 24, 2023 (GLOBE NEWSWIRE) — PERSEUS MINING UPDATES MINERAL RESOURCES AND ORE RESERVES EXECUTIVE SUMMARY Perth, Western Australia/August 24, 2023/Perseus Mining Limited (ASX/TSX: PRU) wishes to update the estimates of the Mineral Resources and Ore Reserves at each of its West African operations as summarised below. HIGHLIGHTSPerseus Mining has delivered another year of positive growth from resource definition drilling and studies, leading to an increase to the Measured and Indicated (M&I) Mineral Resource and increase to Proved and Probable Ore Reserves, ensuring the long-term sustainability of the Group’s production profile. The Group’s total M&I Mineral Resources at 30 June 2023 are estimated to be 122.8 Mt grading 1.31 g/t gold, containing 5.2 Moz of gold, compared with the estimate of 30 June 2022 of...

Continue reading

WestBond reports Financial results for the Quarter ended June 30, 2023

DELTA, British Columbia, Aug. 23, 2023 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) has posted a loss of $69,374 (-$0.002 per share) for the three months ended June 30, 2023, compared to a profit of $415,352 ($0.012 per share) for the same period last year. Sales were $2,366,838 for the three months ended June 30, 2023, which is 28.7% lower than for the three months ended June 30, 2022 and 5.7% lower than for the three months ended March 31, 2023. The decrease in sales and profitability are due to the decrease in sales of airlaid parent rolls since the beginning of this quarter. This is because one of our customers had a change in ownership and decided to purchase airlaid parent rolls from their new owner’s supplier. The larger inventory of airlaid parent rolls now allows us to produce finished napkins and wipes,...

Continue reading

Robex Resources Inc. to Present Second Quarter 2023 Results on Tuesday, August 29, 2023

QUÉBEC CITY, Aug. 23, 2023 (GLOBE NEWSWIRE) — Robex Resources Inc. (TSX-V: RBX), announced today that they will be presenting second quarter 2023 results on a live webinar hosted by Renmark Financial on August 29, 2023, at 10:00 AM EDT. Robex Resources Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event. Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s Investor website. REGISTER HERE: https://www.renmarkfinancial.com/events/second-quarter-2023-results-virtual-presentation-tsx-v-rbx-2023-08-29-100000 To ensure smooth connectivity, please access this link using the latest version of Google Chrome. About Robex Resources Inc.Robex is a multi-jurisdictional West African...

Continue reading

Berkley Mourns Passing of Chief Financial Officer Simon Ma

Vancouver, British Columbia, Aug. 23, 2023 (GLOBE NEWSWIRE) — Berkley Renewables Inc. (CSE:BKS) (the “Company”), announces with great sadness the news of the passing of its Chief Financial Officer, Simon Ma, after a brief illness. Matt Wayrynen, President and CEO of Berkley stated “Simon will be deeply missed by all who had the privilege of working with him. He worked tirelessly, and with a level of precision and accuracy that is rarely seen, always with professionalism, grace and humour. Simon was also a strong moral and ethical compass for the Company and his colleagues, and led by example. Our thoughts and prayers are with his family during this difficult time.” The Board has appointed Pamela Saulnier as its Chief Financial Officer, effective immediately. About Berkley Renewables Berkley Renewables Inc. is a growth-oriented...

Continue reading

Lowell Farms Inc. Announces Share Consolidation

SALINAS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born vertically integrated cannabis company with advanced production capabilities including cultivation, extraction, manufacturing, and distribution, announces it is consolidating all of its subordinate voting shares (“Subordinate Voting Shares”) on the basis of one post-consolidation Subordinate Voting Share for every ten pre-consolidation Subordinate Voting Shares, effective August 31, 2023 (the “Effective Date”). The Company’s outstanding super voting shares (“Super Voting Shares”) will also be consolidated on the same basis as of the Effective Date (collectively, the “Consolidation”). As a result of the Consolidation, the number of issued and outstanding Subordinate Voting Shares will be reduced from 112,761,904...

Continue reading

APRINOIA Therapeutics Announces Mutual Termination of Business Combination Agreement with ROSS Acquisition Corp II

CAMBRIDGE, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) — APRINOIA Therapeutics (“APRINOIA”), a global clinical-stage biopharmaceutical company developing novel therapeutics and precision diagnostics for the treatment of neurodegenerative diseases such as Alzheimer’s Disease (“AD”) and Progressive Supranuclear Palsy (“PSP”), announced a mutual termination of its previously announced business combination agreement with Ross Acquisition Corp II (“RAC”), a special purpose acquisition company. The parties entered into a Termination Agreement on August 21, 2023, which is effective immediately and contains mutual releases for claims and liabilities. A copy of the termination agreement is filed as an exhibit to a Current Report on Form 8-K filed by RAC. APRINOIA is developing three platforms to diagnose and treat neurodegenerative disorders...

Continue reading

Lytus Technologies Receives Nasdaq Notification of Noncompliance with Audit Committee Requirements

MUMBAI, INDIA, Aug. 23, 2023 (GLOBE NEWSWIRE) — Lytus Technologies Holdings PTV. Ltd. (the “Company”) (NASDAQ:LYT), a leading global technology-driven services company, today announced that on August 18, 2023, it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“NASDAQ”) indicating that the Company was not in compliance with NASDAQ’s audit committee requirement as set forth in Listing Rule 5605 (the “Rule”) due to the removal of Mr. Sanjeiiv Chaudhry from the Company’s board and audit committee on July 19, 2023. The Notice also states that NASDAQ will provide the Company a cure period in accordance with NASDAQ Listing Rule 5605(c)(4). Pursuant to NASDAQ Listing Rule 5605(c)(4), such cure period shall be until the earlier of the Company’s next annual shareholders’...

Continue reading

Centessa Pharmaceuticals to Present Preclinical Data for Novel Orexin Receptor 2 (OX2R) Agonist at World Sleep Congress

Oral presentation to include preclinical profile for ORX750, Centessa’s first orexin agonist development candidate for the treatment of narcolepsy and other sleep disorders BOSTON and LONDON, Aug. 23, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced that preclinical data for ORX750, its first orexin agonist development candidate, will be featured in an oral presentation at the World Sleep Congress being held on October 20-25, 2023, in Rio de Janeiro, Brazil. ORX750 is an orally administered, selective orexin receptor 2 (OX2R) agonist in preclinical development for the treatment of narcolepsy and other sleep disorders. In addition, Sarah Wurts Black, PhD, Head of Biology...

Continue reading

SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

·       SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”. ·       The combined company expects to receive approximately $13.0 million of gross proceeds at closing, including $12.0 million from non-redeeming holders of SEPA’s Class A common stock and other PIPE investors, and $1.0 million from the SPAC sponsor converting a loan into equity on the same terms as the PIPE.  Approximately $8.5 million of capital has already been committed. ·       This funding is expected to be anchored by investors affiliated with Sweat Equity Partners and Mercury Life Sciences.  The Company plans to solicit further participation from SANUWAVE’s existing investor base, other...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.